PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
28-Jan-2020 Abivax to Host Satellite Symposium at 15th Congress of the European Crohn's and Colitis Organization (ECCO) in Vienna ABIVAX
28-Jan-2020 Registration Opens for SMi’s 20th Annual Pain Therapeutics Conference SMi Group
28-Jan-2020 SAGA Diagnostics Extends its Collaboration with Servier to Use Ultrasensitive SAGAsafe® Technology in Cancer Clinical Trials B3C newswire
28-Jan-2020 Santen Receives INESSS Recommendation for Verkazia(TM) (cyclosporine 0.1%) Eye Drops Santen
28-Jan-2020 BioIntelliSense Announces FDA Clearance of the BioSticker(TM), the First Single-Use Medical Device Enabling 30 Days of Continuous Vital Signs Monitoring BioIntelliSense, Inc.
28-Jan-2020 BioIntelliSense Announces FDA Clearance of the BioSticker(TM), the First Single-Use Medical Device Enabling 30 Days of Continuous Vital Signs Monitoring BioIntelliSense, Inc.
28-Jan-2020 Santen Receives INESSS Recommendation for Verkazia(TM) (cyclosporine 0.1%) Eye Drops Santen
28-Jan-2020 CytoSorb, the Wuhan Coronavirus, and Cytokine Storm CytoSorbents Corporation
28-Jan-2020 aap Implantate AG: FY/19: Good fourth quarter with EUR 3.1 million revenue (+17%) results in 9% revenue growth in fiscal year 2019 - Milestones in key technologies silver coating and magnesium-based implants aap Implantate AG
27-Jan-2020 Tuberous Sclerosis Alliance Lauds Lundbeck And FDA For Sabril Label Expansion For Patients 2 To 10 Years Old Tuberous Sclerosis Alliance
27-Jan-2020 Drug product formulation and control strategies discussed at PFS East Coast SMi Group
27-Jan-2020 Join experts within supply and demand at Europe’s Only Parallel Trade Conference 2020 in London SMi Group
27-Jan-2020 Bionetix, ProQinase, and MercachemSyncom Announce a Joint Research Project from Target Identification to Clinical Study B3C newswire
27-Jan-2020 Noscendo Expands Proprietary Diagnostic Platform DISQVER to Include Microbial Resistances in Partnership with University Hospital Bonn B3C newswire
24-Jan-2020 Endo to Announce Fourth-Quarter and Full-Year 2019 Financial Results Endo International plc
24-Jan-2020 Capital BlueCross Joins New Effort to Improve Generic Drug Access, Affordability Capital BlueCross
24-Jan-2020 Dupixent®▼ (dupilumab), accepted for restricted use within NHS Wales for the treatment of moderate to severe atopic dermatitis in adolescents aged 12 years and over1 Sanofi
24-Jan-2020 Dupixent®▼ (dupilumab) available to treat adolescents with moderate to severe atopic dermatitis in Scotland1 Sanofi
24-Jan-2020 Johnson & Johnson Announces $250 Million Commitment to Support Frontline Health Workers, Reaching 100 Million People by 2030 Davos
24-Jan-2020 Xlife Sciences AG: New project in the portfolio Xlife Sciences AG